Baird analyst Eric Coldwell raised the firm’s price target on Labcorp to $285 from $270 and keeps an Outperform rating on the shares. The analyst said the company’s commentary at a conference yesterday provided clarity to the expected incremental tailwinds that were added to the model this year.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on LH:
- Labcorp price target raised to $285 from $270 at Baird
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Labcorp downgraded to Neutral from Buy at Citi
- Bust of smuggling ring likely to beheadwind for LabCorp, says Wells Fargo
- Jana made new buy Freshpet top holding in Q3, also bought Momentive